NovaBay Pharmaceuticals to Hold First Quarter 2023 Conference Call on May 11, 2023
May 04 2023 - 6:50AM
Business Wire
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces
that it will report financial results for the three months ended
March 31, 2023 after market close on Thursday, May 11, 2023 and
will hold an investment community conference call that day
beginning at 4:30 p.m. Eastern time.
Date/Time:
Thursday, May 11, 4:30 p.m. ET /
1:30 p.m. PT
Pre-Registration:
Participants can pre-register for
the conference call here:
Callers who pre-register will be
given a conference passcode and unique PIN to gain immediate access
to the call and bypass the live operator. Participants may
pre-register at any time, including up to and after the call start
time.
Dial In:
Those who choose not to
pre-register can access the live conference call by dialing the
following and requesting the NovaBay Pharmaceuticals call:
866-777-2509 from within the
U.S.
412-317-5413 from outside the
U.S.
The live webcast of the conference call also will be available
on the Events section of the Company website. A replay of the call
will be available beginning two hours after its completion through
June 1, 2023 by dialing 877-344-7529 from within the U.S.,
855-669-9658 from Canada or 412-317-0088 from outside the U.S., and
entering conference ID 7090076. The webcast will also be archived
here.
About NovaBay Pharmaceuticals, Inc:
NovaBay Pharmaceuticals, Inc. develops and sells scientifically
created and clinically proven eyecare and skincare products.
NovaBay’s leading product, Avenova® Antimicrobial Lid & Lash
Solution, is often prescribed by eyecare professionals for
blepharitis and dry-eye disease and is also available directly to
eyecare consumers through online distribution channels such as
Amazon. DERMAdoctor® offers more than 30 OTC
dermatologist-developed skincare products through the DERMAdoctor
website, well-known traditional and digital beauty retailers, and
international distributors. NovaBay also manufactures and sells
effective, yet gentle and non-irritating wound care products. The
PhaseOne® brand is distributed through commercial partners in the
U.S. for professional use only, and the NeutroPhase® brand is
distributed in China by Pioneer Pharma (Hong Kong) Company Ltd.
Socialize and Stay Informed on
NovaBay’s Progress
Like us on Facebook Follow us on Twitter Connect with NovaBay on
LinkedIn Visit NovaBay’s Website
Avenova Purchasing
Information
For NovaBay Avenova purchasing information: Please call
800-890-0329 or email sales@avenova.com Avenova.com
DERMAdoctor Purchasing
Information
For DERMAdoctor purchasing information: Please call 877-337-6237
or email service@dermadoctor.com DERMAdoctor.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230504005198/en/
NovaBay Contact Justin Hall
Chief Executive Officer and General Counsel 510-899-8800
jhall@novabay.com
Investor Contact LHA
Investor Relations Jody Cain 310-691-7100 jcain@lhai.com
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Mar 2024 to Apr 2024
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Apr 2023 to Apr 2024